Key Role of Platelet Procoagulant Activity in Tissue Factor-and Collagen-Dependent Thrombus Formation in Arterioles and Venules In Vivo Differential Sensitivity to Thrombin Inhibition

REFERENCES

• André P, Delaney S M, LaRocca T, Vincent D, DeGuzman F, Jurek M, Koller B, Phillips D R, Conley P B. P2Y12 regulates platelet adhesion/ activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003; 112: 398–406
   PubMed Web of Science ®Google Scholar
• Baird T R, Walsh P N. The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation. J Biol Chem 2002; 277: 38462–38467
   PubMedGoogle Scholar
• Baker M, Wayland H. Online volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 1974; 7: 131–143
   PubMed Web of Science ®Google Scholar
• Beguin S, Kumar R. Thrombin, fibrin and platelets: a resonance loop in which von Willebrand factor is a necessary link. Thromb Haemost 1997; 78: 590–594
   PubMed Web of Science ®Google Scholar
• Butenas S, Cawthern K M, van't Veer C, DiLorenzo M E, Lock J B, Mann K G. Antiplatelet agents in tissue factor-induced blood coagulation. Blood 2001; 97: 2314–2322
   Google Scholar
• Camire R M, Kalafatis M, Simioni P, Girolami A, Tracy P B. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood 1998; 91: 2818–2829
   Google Scholar
• Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie B C, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190–3197
   PubMed Web of Science ®Google Scholar
• Cui J, Eitzman D T, Westrick R J, Christie P D, Xu Z J, Yang A Y, Purkayastha A A, Yang T L, Metz A L, Gallagher K P, Tyson J A, Rosenberg R D, Ginsburg D. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood 2000; 96: 4222–4226
   PubMed Web of Science ®Google Scholar
• Day S M, Reeve J L, Pedersen B, Farris D M, Myers D D, Im M, Wakefield T W, Mackman N, Fay W P. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005; 105: 192–198
   PubMed Web of Science ®Google Scholar
• Denis C, Methia N, Frenette P S, Rayburn H, Ullman Cullere M, Hynes R O, Wagner D D. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 1998; 95: 9524–9529
   PubMed Web of Science ®Google Scholar
• Dirkx A E, Oude Egbrink M G, Kuijpers M J, van der Niet S T, Heijnen V V, Bouma-ter Steege J C, Wagstaff J, Griffioen A W. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 2003; 63: 2322–2329
   PubMed Web of Science ®Google Scholar
• Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie B C. Glycoprotein VI-dependent and-independent pathways of thrombus formation in vivo. Blood 2006; 107: 3902–3906
   PubMed Web of Science ®Google Scholar
• Eitzman D T, Westrick R J, Shen Y, Bodary P F, Gu S, Manning S L, Dobies S L, Ginsburg D. Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation 2005; 111: 1822–1825
   Google Scholar
• Falati S, Gross P, Merrill-Skoloff G, Furie B C, Furie B. Real-time in vivo imaging of platelets, tissue factor, and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175–1181
   PubMed Web of Science ®Google Scholar
• Golino P, Cimmino G. Targeting tissue factor as an antithrombotic strategy. Semin Vasc Med 2003; 3: 205–214
   Google Scholar
• Gustafsson D, Elg M. The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. Thromb Res 2003; 109: S9–S15, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Heemskerk J WM, Kuijpers M JE, Munnix I CA, Siljander P R. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med 2005; 15: 86–92
   PubMedGoogle Scholar
• Heemskerk J WM, Vuist W M, Feijge M A, Reutelingsperger C P, Lindhout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2 + responses. Blood 1997; 90: 2615–2625
   PubMed Web of Science ®Google Scholar
• Heemskerk J WM, Bevers E M, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186–193
   PubMed Web of Science ®Google Scholar
• Hemker H C, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4–15
   PubMed Web of Science ®Google Scholar
• Kenis H, Van Genderen H, Bennaghmouch A, Rinia H A, Frederik P, Narula J, Hofstra L, Reutelingsperger C P. Cell surface expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J Biol Chem 2004; 279: 52623–52629
   PubMed Web of Science ®Google Scholar
• Kuijpers M JE, Schulte V, Bergmeier W, Lindhout T, Brakebusch C, Offermanns S, Fassler R, Heemskerk J WM, Nieswandt B. Complementary roles of glycoprotein VI and α 2β 1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. Faseb J 2003; 17: 685–687
   PubMed Web of Science ®Google Scholar
• Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015–1022
   PubMed Web of Science ®Google Scholar
• Mangin P, Yap C L, Nonne C, Sturgeon S A, Goncalves I, Yuan Y, Schoenwaelder S M, Wright C E, Lanza F, Jackson S P. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency. Blood 2006; 107: 4346–4353
   PubMed Web of Science ®Google Scholar
• Munnix I CA, Strehl A, Kuijpers M JE, Auger J M, van der Meijden P EJ, van Zandvoort M AMJ, oude Egbrink M GA, Nieswandt B, Heemskerk J WM. The glycoprotein VI-phospholipase Cγ 2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro in vivo. Arterioscler Thromb Vasc Biol 2005; 25: 2673–2678
   PubMedGoogle Scholar
• Ni H, Ramakrishnan V, Ruggeri Z M, Papalia J M, Phillips D R, Wagner D D. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 2001; 98: 368–373
   PubMed Web of Science ®Google Scholar
• Nicolaes G A, Dahlback B. Factor V and thrombotic disease: description of a janus-faced protein. Arterioscler Thromb Vasc Biol 2002; 22: 530–538
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Watson S P. Platelet collagen interaction: is GPVI the central receptor?. Blood 2003; 102: 449–461
   PubMed Web of Science ®Google Scholar
• Egbrink M GA, van Gestel M A, Broeders M D, Tangelder G J, Heemskerk J WM, Reneman R S, Slaaf D W. Regulation of microvascular thromboembolism in vivo. Microcirculation 2005; 12: 287–300
   Google Scholar
• Poole A, Gibbins J M, Turner M, van Vugt M J, van de Winkel J G, Saito T, Tybulewicz V L, Watson S P. The FcRγ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 1997; 16: 2333–2341
   PubMed Web of Science ®Google Scholar
• Reverter J C, Beguin S, Kessels H, Kumar R, Hemker H C, Coller B S. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis”. J Clin Invest 1996; 98: 863–874
   PubMed Web of Science ®Google Scholar
• Sambrano G R, Weiss E J, Zheng Y W, Huang W, Coughlin S R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001; 413: 74–78
   PubMed Web of Science ®Google Scholar
• Siljander P R, Munnix I CA, Smethurst P A, Deckmyn H, Lindhout T, Ouwehand W H, Farndale R W, Heemskerk J W. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 2004; 103: 1333–1341
   PubMed Web of Science ®Google Scholar
• Sorensen B B, Rao L V. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor. Blood Coagul Fibrinolysis 1998; 9: S67–S71, (Suppl. 1)
   Google Scholar
• Swords N A, Mann K G. The assembly of the prothrombinase complex on adherent platelets. Arterioscler Thromb 1993; 13: 1602–1612
   PubMedGoogle Scholar
• Takai T, Li M, Sylvestre D, Clynes R, Ravetch J V. FcRγ-chain deletion results in pleiotrophic effector cell defects. Cell 1994; 76: 519–529
   PubMed Web of Science ®Google Scholar
• Tangelder G J, Slaaf D W, Arts T, Reneman R S. Wall-shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol 1988; 254: H1059–H1064
   PubMedGoogle Scholar
• van Gestel M A, Reitsma S, Slaaf D W, Heijnen V VT, Feijge M AH, Lindhout T, van Zandvoort M AMJ, Elg M, Reneman R S, Heemskerk J WM, oude Egbrink M GA. Both ADP and thrombin regulate arteriolar thrombus stabilization and embolization, but are not involved in initial hemostasis. Microcirculation 2007; 14: 193–205
   PubMed Web of Science ®Google Scholar
• van Gestel M A, Heemskerk J WM, Slaaf D W, Heijnen V VT, Sage S O, Reneman R S, oude Egbrink M GA. Real-time detection of activation patterns in individual platelets during thromboembolism in vivo: differences between thrombus growth and embolus formation. J Vasc Res 2002; 39: 534–543
   PubMed Web of Science ®Google Scholar
• Vanschoonbeek K, Feijge M AH, Van Kampen R J, Kenis H, Hemker H C, Giesen P L, Heemskerk J W. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2004; 2: 476–484
   PubMed Web of Science ®Google Scholar
• Weiss H J. Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol 1994; 31: 312–319
   PubMed Web of Science ®Google Scholar
• Zwaal R FA, Schroit A J. Pathophysiological implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121–1132
   PubMed Web of Science ®Google Scholar